This is a working overview of Reverse-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
Analytical results depend on the column, gradient, and detector wavelength chosen by the laboratory, so purity values from different sources are not always directly comparable. Water content, counterion form, and residual trifluoroacetate affect both mass and purity calculations. Microbiological and endotoxin testing are separate from chemical purity and are not covered by a standard chromatographic run. Buyers evaluating a material typically request the full method description rather than a single purity figure.
Lyophilized peptide powder is generally stored at minus twenty degrees Celsius or lower and kept away from light and moisture. Under these conditions degradation is slow, and sealed vials remain stable for extended periods. Once dissolved, the material is less stable, particularly in aqueous buffers near neutral pH, where hydrolysis and oxidation proceed faster. Solutions are usually kept cold and used within days to weeks. Repeated freeze-thaw cycles are avoided because they encourage aggregation.
| Property | Value | Notes |
|---|---|---|
| Molar mass | Approximately 1419.5 g/mol | Calculated from the reported 15-residue sequence |
| Molecular formula | C62H98N16O22 | Based on the same sequence |
| Appearance | White to off-white powder | Typical of a lyophilized preparation |
| Solubility class | Freely soluble in water | Also dissolves in saline solutions |
| Typical storage temperature | Minus 20 degrees Celsius, dry | Refrigeration advised after reconstitution |
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
Material of this kind is sold for laboratory research, and labels typically state that it is not intended for human or veterinary use. In many countries it is not an approved medicine, and sports antidoping rules place it among prohibited non-approved substances. Buyers commonly review a certificate of analysis, an independent test report, and the declared storage conditions. Batch-to-batch variation in purity and in counterion content is possible, and how much that variation affects experimental outcomes remains an open question.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
MIKES is a powerful technique used for structural studies of organic compounds, gaseous ions, and also for direct analysis of complex mixtures without separation of the components. In other words, it is used for molecular structure studies. The reason why MIKES is good for molecular structure studies is due to the reverse-geometry of MIKES. The MIKES Schematic shows that the ion species in the source goes into the magnetic field. After which, the chemistry is later studied in the second field-free region (FFR) by scanning the electric sector which defines the nature of the fragments by measuring their kinetic energy. This causes competitive unimolecular fragmentations that can be observed in the MIKE spectra. Furthermore, if gas is brought into the second FFR, more dissociation will be induced by collision, that will later appear in the MIKE spectra.
=== 7 February === The SAF claimed to have retaken the Traffic Signs and License Plates Factory along with the entire industrial area of Khartoum. They also claimed to have retaken Al-Masoudiya in Khartoum state and Abu Quta in northwestern Gezira State. The SAF claimed to have shot down seven RSF drones over Debba, Northern State. Three people were killed in an RSF attack on the Zamzam IDP camp. Five others were killed in an RSF attack on Saloma, southeast of El Fasher.
'FWACS' – Fellow of the West African College of Surgeons. Following award of fellowship, the Medical and Dental Council of Nigeria (MDCN) formally recognizes the individual as a specialist/consultant. Fellowship holders are eligible for appointment as consultant physicians, surgeons, dentists, or radiologists in teaching hospitals, federal medical centers, and tertiary institutions. They may also teach in universities and residency training programs or set up specialist private practices. Some specialties (e.g., Cardiology, Gastroenterology, Paediatric Surgery, Interventional Radiology) offer post-fellowship subspecialty training within or outside Nigeria. Increasingly, Nigerian-trained fellows pursue international fellowships or enroll in academic doctorate (PhD) programs, especially in research-intensive disciplines. The FWACP and FWACS are widely recognized across Anglophone West Africa. NPMCN and WACP/WACS fellowships are increasingly acknowledged in Europe, North America, and the Middle East, although individual recognition often requires equivalence assessments or registration with local medical councils (e.g., GMC in the UK). Many Nigerian-trained specialists have transitioned into international academic, clinical, or humanitarian roles, especially in underserved or diaspora communities. In South Africa, successful completion of residency leads to board certification as a specialist with the Health Professions Council and eligibility for fellowship of the Colleges of Medicine of South Africa.
== External links == Phil Baran: Molecule Magician, The Scientist Magazine The sultan of synthesis, Chemistry World, Royal Society of Chemistry Evolution from Academia to Industry – Interview with Professor Phil S. Baran, Oxbridge Biotech Roundtable
Sertraline is a selective serotonin reuptake inhibitor (SSRI). By binding to the serotonin transporter (SERT) it inhibits neuronal reuptake of serotonin and potentiates serotonergic activity in the central nervous system. Over time, this leads to a downregulation of pre-synaptic 5-HT1A receptors, which is associated with an improvement in passive stress tolerance, and delayed downstream increase in expression of brain-derived neurotrophic factor (BDNF), which may contribute to a reduction in negative affective biases. It does not significantly affect histamine, acetylcholine, GABA or benzodiazepine receptors. Sertraline also shows relatively high activity as an inhibitor of the dopamine transporter (DAT) occupying ~20% of DAT receptors at doses 200mg and above, and antagonist of the sigma σ1 receptor (but not the σ2 receptor). However, sertraline affinity for its main target (SERT) is much greater than its affinity for σ1 receptor and DAT. Although there could be a role for the σ1 receptor in the pharmacology of sertraline, the significance of this receptor in its actions is unclear. Similarly, the clinical relevance of sertraline's blockade of the dopamine transporter is uncertain. Sertraline is a REDD1-dependent mTOR inhibitor. It blocks AKT/mTOR pathway and has autophagy-inducing activity.
Sources: en.wikipedia.org
== Known members == For a key to the single-letter sequences, see Amino acid § Table of standard amino acid abbreviations and properties. All peptides sequences are assumed to start with NH2- and end with -COOH, unless otherwise stated.
Artistic Achievement – Lumino City Audio Achievement – Alien: Isolation Best Game – Destiny British Game – Monument Valley Debut Game – Never Alone Family – Minecraft: Console Editions Game Design – Middle-earth: Shadow of Mordor Game Innovation – The Vanishing of Ethan Carter Mobile & Handheld – Monument Valley Online Multiplayer – Hearthstone: Heroes of Warcraft Original Music – Far Cry 4 Original Property – Valiant Hearts: The Great War Performer – Ashley Johnson (as Ellie, The Last of Us: Left Behind) Persistent Game – League of Legends Sports – OlliOlli Story – The Last of Us: Left Behind BAFTA Ones to Watch Award – Chambara Academy Fellowship – David Braben
== Diagnosis == One of the most important factors used to determine the clinical suspicion of malignancy of an adnexal mass is the sonographic (ultrasound) appearance of the mass. Indications that the mass is at a higher risk of being malignant include the presence of loculations, nodules, papillary structures, septations, or a size greater than 10 cm.
In 1917, Burnie Lee Benbow was granted a patent for the coiled coil filament, in which a coiled filament is then itself wrapped into a coil by use of a mandrel. In 1921, Junichi Miura created the first double-coil bulb using a coiled coil tungsten filament while working for Hakunetsusha (a predecessor of Toshiba). At the time, machinery to mass-produce coiled coil filaments did not exist. Hakunetsusha developed a method to mass-produce coiled coil filaments by 1936. Between 1924 and the outbreak of the Second World War, the Phoebus cartel attempted to fix prices and sales quotas for bulb manufacturers outside of North America. In 1925, Marvin Pipkin, an American chemist, patented a process for frosting the inside of lamp bulbs without weakening them. In 1947, he patented a process for coating the inside of lamps with silica. In 1930, Hungarian Imre Bródy filled lamps with krypton gas rather than argon, and designed a process to obtain krypton from air. Production of krypton filled lamps based on his invention started at Ajka, Hungary in 1937, in a factory co-designed by Polányi and Hungarian-born physicist Egon Orowan. By 1964, improvements in efficiency and production of incandescent lamps had reduced the cost of providing a given quantity of light by a factor of thirty, compared with the cost at introduction of Edison's lighting system. Consumption of incandescent light bulbs grew rapidly in the US. In 1885, an estimated 300,000 general lighting service lamps were sold, all with carbon filaments.
Sources: en.wikipedia.org
It does not occur in the form that is supplied commercially. Its sequence matches a fragment of a larger gastric protein, and the research material is produced synthetically in a laboratory. The fragment described in the early literature is generally the same synthetic pentadecapeptide.
It marks the position of the sequence inside the original protein. The label traces back to early work fractionating gastric juice and describing a body protection compound. The figure does not refer to molecular weight or to the count of amino acids.
No. The sequence has no cysteine residues, so disulfide bridges cannot form. That feature makes it easier to handle than many small proteins that depend on multiple cysteines for structure.
Bacteriostatic water or sterile saline is commonly used to dissolve the powder. The choice of solvent affects stability and preservation. Aqueous solutions are kept refrigerated and are not intended for long-term storage.